Back
Arrowhead Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
17
ARWR
Arrowhead Pharmaceuticals
Last Price:
$19.56
Seasonality Move:
23.49%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARWR is experiencing slight buying pressure.
Arrowhead Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.65 | Sell |
| 20-day SMA: | 22.6 | Sell |
| 50-day SMA: | 21.13 | Sell |
| 200-day SMA: | 23.59 | Sell |
| 8-day EMA: | 20.52 | Sell |
| 20-day EMA: | 21.33 | Sell |
| 50-day EMA: | 21.39 | Sell |
| 200-day EMA: | 23.69 | Sell |
Arrowhead Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 40.53 | Sell |
| Chaikin Money Flow: | 158982 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.23 - 24.35) | Sell |
| Bollinger Bands (100): | (19.22 - 23.64) | Sell |
Arrowhead Pharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arrowhead Pharmaceuticals Stock
Is Arrowhead Pharmaceuticals Stock a Buy?
-
Arrowhead Pharmaceuticals share price is 19.63 while ARWR 8-day simple moving average is 20.65, which is a Sell signal.
-
The stock price of ARWR is 19.63 while Arrowhead Pharmaceuticals 20-day SMA is 22.60, which makes it a Sell.
-
Arrowhead Pharmaceuticals 50-day simple moving average is 21.13 while ARWR share price is 19.63, making it a Sell technically.
-
ARWR stock price is 19.63 and Arrowhead Pharmaceuticals 200-day simple moving average is 23.59, creating a Sell signal.
ARWR Technical Analysis vs Fundamental Analysis
Sell
17
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy or a Sell?
-
Arrowhead Pharmaceuticals stock is rated a SellThe current Arrowhead Pharmaceuticals [ARWR] share price is $19.63. The Score for ARWR is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Arrowhead Pharmaceuticals Stock Info
Market Cap:
2.5B
Price in USD:
19.63
Share Volume:
590K
Arrowhead Pharmaceuticals 52-Week Range
52-Week High:
39.83
52-Week Low:
17.05
Sell
17
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Arrowhead Pharmaceuticals Share Price Forecast
-
What is the Arrowhead Pharmaceuticals stock price today?The Arrowhead Pharmaceuticals stock price is 19.63 USD today.
-
Will ARWR stock go up or go down?Arrowhead Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Arrowhead Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arrowhead Pharmaceuticals is overvalued.
Is Arrowhead Pharmaceuticals Stock a Buy?
-
Arrowhead Pharmaceuticals share price is 19.63 while ARWR 8-day exponential moving average is 20.52, which is a Sell signal.
-
The stock price of ARWR is 19.63 while Arrowhead Pharmaceuticals 20-day EMA is 21.33, which makes it a Sell.
-
Arrowhead Pharmaceuticals 50-day exponential moving average is 21.39 while ARWR share price is 19.63, making it a Sell technically.
-
ARWR stock price is 19.63 and Arrowhead Pharmaceuticals 200-day simple moving average is 23.69, creating a Sell signal.
Fundamental Analysis of Arrowhead Pharmaceuticals
Is Arrowhead Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.11 per share, and an increase next year of $1.17 per share.
Technical Analysis of Arrowhead Pharmaceuticals
Should I short Arrowhead Pharmaceuticals stock?
-
ARWR Moving Average Covergence Divergence (MACD) indicator is -0.41, suggesting Arrowhead Pharmaceuticals is a Sell
-
Arrowhead Pharmaceuticals Relative Strength Index (RSI) is 40.53, which suggest Arrowhead Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Arrowhead Pharmaceuticals is (19.23 - 24.35), which suggest Arrowhead Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Arrowhead Pharmaceuticals is (19.22 - 23.64), which suggest Arrowhead Pharmaceuticals is a Sell
* Arrowhead Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.